Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) <i>via</i> retrospective analyses in Okinawa, Japan-Reference-Cited by-同舟云学术

Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) <i>via</i> retrospective analyses in Okinawa, Japan

Published:2024 Issue:9 Volume:71 Page:895-906
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Honma Ken-ichiro¹,Nakayama Yoshiro¹,Tamaki Atsuko¹,Uehara Moriyuki¹,Teruya Taiki¹,Yabiku Takamitsu¹,Ishiki Yohei¹,Yonaha Ken¹,Chinen Rei¹,Uema Tsugumi¹,Okamoto Shiki¹,Masuzaki Hiroaki¹^ORCID

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/9/71_EJ24-0227/_pdf

Reference32 articles.

1. 1 Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, et al. (2016) Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab 101: 2826–2835.

2. 2 Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies—a review of the current literature. Horm Metab Res 44: 157–162.

3. 3 Burrello J, Monticone S, Losano I, Cavaglià G, Buffolo F, et al. (2020) Prevalence of hypokalemia and primary aldosteronism in 5,100 patients referred to a tertiary hypertension unit. Hypertension 75: 1025–1033.

4. 4 Savard S, Amar L, Plouin PF, Steichen O (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62: 331–336.

5. 5 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530–537.